CINNARIZINE

Cinnarizine is a calcium channel blocker used for vertigo and motion sickness. Side effects include drowsiness, weight gain, and dry mouth. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 787bb839edbf Category: Tag:

Product Description


Mechanism of Action

Cinnarizine is a calciumchannel blocker with antihistaminic (H) and antivertigo properties. It inhibits Ltype calcium channels, reducing smoothmuscle contractility, while its Hantagonism suppresses vestibular nuclei excitabilityuseful in motionsickness research. It also improves microcirculation by reducing blood viscosity.

Benefits and Advantages

Used in vestibularfunction studies, motionsickness modelling, calciumchannel pharmacology, cerebralperfusion research and combined antihistaminevasodilator SAR investigations.

Side Effects and Risks

Risks include sedation, weight gain, extrapyramidal symptoms (rare), dry mouth and hypotension. Handle with CNSactive calciumantagonist precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C26H28N2

Molecular Weight

368.5 g/mol

CAS Number

298-57-7

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

1.72e-03 g/L

Purity

Purity information is available upon request (COA).

Synonym

cinnarizine; 298-57-7; Stugeron; Dimitron; Folcodal

IUPAC/Chemical Name

1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine

InChl Key

DERZBLKQOCDDDZ-JLHYYAGUSA-N

InChl Code

InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+

References

https://pubchem.ncbi.nlm.nih.gov/compound/1547484;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download